Document is current

Article History

Received: 16 May 2024

Accepted: 30 October 2024

First Online: 27 November 2024

Declarations

:

: Informed consent was obtained from all study subjects. The Institutional Review Board of the University of Gondar and the School of Pharmacy provided full approval for the study with a reference number UOG-Sop/257/2022 and the research was conducted in accordance with the Declaration of Helsinki. The clinical directorate of the hospital issued a letter of authorization. Before proceeding to the interview, a short background, purpose of the research, the risk imposed to participants, and steps to protect the confidentiality of information obtained from the patients were provided to the patients. Those who were able to read gave the consent by reading and signing by themselves. Whereas, in those who cannot read and write, the interviewer read and assisted them to sign (thumbprint). They were also informed that participation will not affect any future medical services and/or benefits received. In addition, they were informed that participation was voluntary and they could withdraw from the study at any stage if they desired. All participants were also made aware that taking part in the study was completely optional and that they might stop at any time if they found the questionnaire to be uncomfortable. The study participants’ information was not recorded in any way.

: The authors declare no competing interests.